ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SHPH Shuttle Pharmaceuticals Holdings Inc

0.3992
0.0102 (2.62%)
Apr 25 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 15,054
Bid Price 0.374
Ask Price 0.417
News -
Day High 0.3998

Low
0.35

52 Week Range

High
2.75

Day Low 0.3885
Company Name Stock Ticker Symbol Market Type
Shuttle Pharmaceuticals Holdings Inc SHPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0102 2.62% 0.3992 18:00:05
Open Price Low Price High Price Close Price Prev Close
0.394249 0.3885 0.3998 0.3992 0.389
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
73 15,054 $ 0.3930899 $ 5,918 - 0.35 - 2.75
Last Trade Time Type Quantity Stock Price Currency
18:54:30 2 $ 0.417 USD

Shuttle Pharmaceuticals Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
6.4M 16.00M - 0 -6.59M -0.41 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Shuttle Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SHPH Message Board. Create One! See More Posts on SHPH Message Board See More Message Board Posts

Historical SHPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.400.42990.37050.389909414,188-0.0008-0.20%
1 Month0.4290.43990.37050.415429236,362-0.0298-6.95%
3 Months0.41980.5450.350.412845452,432-0.0206-4.91%
6 Months0.510.61830.350.46602106,701-0.1108-21.73%
1 Year1.582.750.351.26463,016-1.18-74.73%
3 Years24.05126.260.357.56860,715-23.65-98.34%
5 Years24.05126.260.357.56860,715-23.65-98.34%

Shuttle Pharmaceuticals Description

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Your Recent History

Delayed Upgrade Clock